Award Date
5-1-2013
Degree Type
Thesis
Degree Name
Master of Science (MS)
Department
Health Physics and Diagnostic Sciences
First Committee Member
Steen Madsen
Second Committee Member
Ralf Sudowe
Third Committee Member
Gary Cerefice
Fourth Committee Member
Daniel Young
Number of Pages
64
Abstract
Treatments for glioblastoma multiforme and invasive ductal carcinoma involve surgical resection and adjuvant or concurrent targeted therapies. The goal of the secondary treatment is to reduce the cancer cells in the resection margin and other areas of suspected involvement. Photochemical internalization is a targeted therapy using light to activate photosensitizers embedded in cellular structures to improve the delivery of macromolecules within the cell.
In a previous study, optimized treatment parameters including radiant exposure, and irradiance, concentration of AlPcS(2a), temperature, and the concentration of bleomycin were determined for human ACBT glioma multicell spheroids. The current study investigates the effectiveness of the ACBT-optimized concurrent PCI/hyperthermia treatment for F98 rat glioma and MCF-7 human invasive ductal carcinoma spheroids. The combination of photochemical internalization and hyperthermia was shown to be more effective than either treatment modality alone and, in all cases, the combined treatments interacted in a synergistic manner.
Keywords
F98; Glioblastoma multiforme – Treatment; Heat – Physiological effect; Hyperthermia; MCF-7; Multicellular tumor spheroids; Photochemical internalization; Photochemotherapy; Photodynamic therapy; Phototherapy
Disciplines
Medicine and Health Sciences | Oncology | Physics
File Format
Degree Grantor
University of Nevada, Las Vegas
Language
English
Repository Citation
Andersen, Aaron, "AlPcS(2a)-Mediated Photochemical Internalization of Bleomycin and Concurrent Hyperthermia of Multicellular Tumor Spheroids" (2013). UNLV Theses, Dissertations, Professional Papers, and Capstones. 1794.
http://dx.doi.org/10.34917/4478188
Rights
IN COPYRIGHT. For more information about this rights statement, please visit http://rightsstatements.org/vocab/InC/1.0/